You made the right decision.
Trust one of Germany’s leading Corporate Finance Experts.Tailored to your needs.
We are specialized consultants for Equity and Debt Financing, Mergers and Acquisitions (M&A), Management Participation Programs in Private Equity Transactions and Management Incentives for publicly listed and private companies, Investor Relations Management and general Advisory Services.
Our clients are owner-managed companies, medium-sized and large international corporations, as well as private and institutional investors. More than 500 transactions are proof of our expertise. Our established interdisciplinary competence network, the high level of customer satisfaction and numerous publications on important corporate finance topics reflect our recognized reputation.
Management
Our Services for you
Equity Advisory
& ECM
- Initial Public Offering (IPO)
- Capital Increase
- Equity Financing through our Family Office and Private Equity Network
- Mezzanine Financing
Debt Advisory
& DCM
- Corporate Bonds
- Promissory Notes
- Private Debt
- Consortium and Syndicate Loans
Mergers & Acquisitions
(M&A)
- Buy-side Transactions
- Sell-side Transactions
- Succession Planning
Management Equity
Program / Compensation
- Management Equity Programs in Private Equity Transactions
- Compensation Systems for the Executive Board and the Top Management
- Standard and virtual Management Participation Programs for family owned companies
Capital Market
Support
- Preparation of Roadshows and Investor Conferences
- Optimization of Corporate News and obligatory reporting
- Management of Stock Price
National and European
Funding Programs
- Information about National and European Funding Programs for companies
- Analysis, whether conditions to avail Funding Program(s) can be met
- Support of application process for National and European Funding Programs
Current News, Publications and Events
Blättchen& Partner advises The Management of PharmaZell on the sale to Bridgepoint
International private equity investor Bridgepoint acquires a majority stake in PharmaZell from DPE Deutsche Private Equity and Maxburg Capital Partners. The parties have agreed not to disclose the purchase price. PharmaZell is a leading independent manufacturer of...
The market for new stock issues in Germany – 2019 a disappointment
CORPORATE FINANCE No. 01-02 31.01.2020 by Dr. Konrad Bösl Although at the end of the year the Saudi oil company Saudi Aramco completed its largest IPO to date, with an issue volume of USD 25.6 billion excluding greenshoe, the global market for new issues in 2019 was...
Rosenberger Hochfrequenztechnik acquires majority stake in Aifotec AG
The Rosenberger Hochfrequenztechnik GmbH & Co. KG has acquired the majority interest in Aifotec AG from GUB Investment Trust GmbH & Co. KGaA. With the majority acquisition Rosenberger wants to further expand its competence in photonics and microassembly....
Critical Review of the Year – New Share Issues 2019
Current study at the end of the new issue year 2019 by Dr. Konrad Bösl, Konstantin Dudeck and Christian Oßwald. Study "Critical Review of the Year - New Share Issues 2019" as pdf. Blättchen & Partner presents its annual review of new issues in 2019 Global decline...
IPOs in 2019 – A complete Disappointment
Blättchen & Partner presents its annual review of new issues in 2019. After the medical technology company DiaMonTech had to cancel its IPO at the end of the subscription period due to insufficient demand, the new issue year 2019 has come to an end in Germany. A...
Certificate course M&A 2020 at the Westphalian Wilhelms-University Münster in cooperation with JurGrad gGmbH
Tuesday 23 - Saturday, 27 June 2020 The course provides the basics for successfully performing M&A transactions. It is aimed at newcomers and professionals with up to three years of professional experience, from all areas of M&A practice. But even participants...